Research Lab | 8:03 AM
Dr. Reyes stood at the whiteboard. She was a small, precise woman with silver-streaked hair and reading glasses pushed up into it like she'd forgotten they were there, or like she'd given up on pretending there was anywhere else she needed to be. Her coat was immaculate. She had the posture of someone who had been in this room since before any of them arrived and who would be in it long after they left, who had been staring at this vial and this whiteboard and these conclusions since approximately 3 AM and had arrived at the specific kind of calm that comes from having looked at a terrible thing for so long that it stops being surprising and becomes simply the problem you are solving.
The whiteboard behind her was covered in structured notation: columns of compound names, molecular structures rendered in careful marker strokes, arrows tracing interactions like a map of something terrible, a colour-coded key along the left margin.
She didn't wait for introductions.
She didn't ask how they were.
She uncapped her marker, pointed to the top of the board, and began.
"The base compound is a modified organophosphate nerve agent. Structurally similar to VX."
She tapped the notation — C₁₁H₂₆NO₂PS — with the marker tip.
"What does structurally similar mean in practical terms?" Adrian asked. Not because he didn't understand the words. Because he needed to understand the scope.
"VX in its stable form is an amber oily liquid. Odourless. Low volatility. Extraordinarily persistent on surfaces." She turned back to the board. "In its stable form. It works by irreversibly inhibiting acetylcholinesterase — the enzyme that breaks down acetylcholine in the nervous system."
"Which means?"
"Without it, nerve signals don't stop." She said it the way you'd describe a mechanical fault. Like she was explaining a broken gear. "Muscles lock. The diaphragm fails. Respiratory failure follows. Skin contact with a quantity measured in micrograms is sufficient to kill an adult."
The fluorescent lights hummed their indifferent hum. One of the refrigeration units cycled on with a low mechanical shudder, and then settled.
Adrian was doing the math. The math was not good. The math was very not good.
"There's more," Aveline said. Not a question.
"There's more," Dr. Reyes confirmed. She moved along the board. "The serum also contains botulinum-derived peptides. Botulinum toxin blocks acetylcholine release at the neuromuscular junction — mechanistically the opposite of VX, but combined, the neuromuscular effect is compounding. Shutdown from both ends simultaneously." She didn't pause for reaction. "Additionally, ricin-derived peptides. Ricin inhibits protein synthesis at the cellular level. Cells stop functioning. Then they die."
"Three agents in one compound," Elias said.
"Layered. Each one reinforcing the failure mode of the others." She set the marker down. Picked it back up. Seemed to decide against using it and set it back down again with the care of someone handling something fragile. "Whoever designed this understood exactly what they were building. The formulation is technically exceptional." She said exceptional the way most people say unconscionable.
"And the delivery system?" Aveline asked.
"PEGylated liposomes. Polyethylene glycol conjugates wrapped around lipid vesicles — legitimate pharmaceutical technology. Used in cancer treatment." A brief pause, the weight of that sitting in the air. "Here it makes the compound stealthy. Extends circulation time in the body. Allows it to cross barriers it has no business crossing."
"Meaning," Adrian said carefully, "this was designed by someone who understood pharmaceutical development. Not a weapons lab working in isolation."
"Yes." Dr. Reyes looked at him with the attention of someone recalibrating their audience upward. "Exactly that. This required resources, infrastructure, and specific institutional knowledge that doesn't exist outside of advanced pharmaceutical research."
The word Nexo sat in the room without anyone saying it. It was already implied. It had been implied since the vial arrived.
"And the colour," Elias said. "Explain the colour."
"The stabilizer is missing." She pointed to the containment unit. To the green. The specific green that was wrong in every measurable way. "NexoStab-7. Nexo Pharmaceuticals' proprietary compound — patented, no published formula. Without it, the organophosphate base hydrolyzes in the presence of ambient moisture. Breaks down."
"So the green means—"
"The amber colour is the stable, weaponized state." She looked at the vial with the expression of someone who had been staring at a problem long enough to start understanding its implications personally. "Green is what you get when the architecture starts to collapse."
"And if the architecture collapses," Aveline said, "what do we lose?"
Dr. Reyes looked at her for a moment.
"The mutagenic capacity. The DNA modification mechanism. The transmissibility — the property that would allow it to spread person to person, to rewrite human biology at a cellular level." She let that sit for exactly as long as it needed to. "None of that survives without NexoStab-7. What remains is still a potent nerve agent. It would still kill, quickly and badly. But it wouldn't mutate. It wouldn't spread."
She looked at the room. At Adrian. At Aveline. At Elias. The look of someone who needed to make sure this next part landed correctly.
"It's the difference between a weapon and an apocalypse."
The sentence sat in the cold air and didn't move.
Adrian thought: We fell halfway down a building. We stole a car. We drove it across active train tracks with a thirty-two-car freight train visible and closing. We brought back the vial. We went through all of that and we came back with the vial and the vial is green and the green means it's wrong.
He thought: we spent twelve hours risking our lives for the non-apocalypse version of the apocalypse serum.
"They're hiding the real one elsewhere," Aveline said.
Her voice was completely level. You would never know she hadn't slept. You would never know she was in pain. You would never know that she was running calculations in her head about what came next, about where the real serum was, about what it meant that Nexo had let them take this one — this wrong one — without making it harder.
"Two possibilities," Dr. Reyes said. "The stabilized amber serum is stored at a separate facility. Or Nexo intentionally reformulated to remove the transmissible properties."
"They didn't reformulate." Aveline said it without inflection. It wasn't a guess. It was a read — of the company, of their operational character, of the particular flavour of their ambition. "That's not who they are."
Dr. Reyes studied her for a moment. The particular attention of someone who has just recalibrated what this person knows and how they know it.
"No," she said finally. "Their history doesn't support the charitable interpretation."
Elias turned toward Aveline.
"Get your hand seen to," he said. It was no longer a suggestion. "Adrian and I will work through the location data with the team."
She nodded once and left.
The lab was colder when she was gone.
Medical Wing | 8:31 AM
The medical wing was warmer than the lab. It smelled like antiseptic and recycled air and somewhere down the corridor, someone's coffee — the kind of coffee that had been made at 6 AM and had been sitting in a mug ever since, the kind that tasted like resignation when you finally got around to drinking it.
The nurse on duty looked up when Aveline walked in.
Her name was Katherine. Aveline knew this because she made it a point to know the names of the people who had access to her bloodstream and her injured extremities, on the reasonable theory that if someone was going to tell her things she didn't want to hear about her own body, the least she could do was know what to call them.
Katherine took in the state of the bandaging with the particular expression of medical professionals confronted with injuries left longer than advised — that specific blend of I knew this was going to happen and I can't believe you actually left it this long. She had the kind of face that gave nothing away in a crisis and everything away in the thirty seconds afterward, when the professional mask slipped just far enough to let you know she'd been doing math about your life expectancy and the numbers were suboptimal.
She pulled on gloves with the efficiency of someone who'd done this motion enough times that her hands could do it in their sleep.
"Back again." She looked at the hand. Then at Aveline. The look lasted half a second longer than clinical assessment required. "You really need to stop collecting injuries."
"What can I say." Aveline sat on the edge of the examination table. The paper crinkled under her weight. "The service here is excellent."
"Mm." Katherine began unwinding the old bandaging with practiced efficiency. She had the hands of someone who'd done this a thousand times and the focus of someone who was simultaneously paying attention to two things at once — the wound and the patient — and filing information from both. "You're not what I was briefed on."
"I'm not briefed on," Aveline said. "I'm assigned to."
"There's a difference."
"There's always a difference."
Katherine made a sound that wasn't quite agreement. What was underneath the bandaging had not improved with time — the bruising had deepened overnight into something genuinely impressive, purple and spreading in thin lines along the tendons like a map of somewhere you wouldn't want to go. Too dark. The kind of dark that meant the blade had gone deeper than just through skin and fat. That meant it had meant something.
She didn't react.
That was the thing about good medical staff. They looked at the bad thing and their face said noted and they moved on, didn't waste time with expressions of surprise or concern because expressing surprise about injuries just wasted time that could be spent fixing them.
"Left it a while," she said.
"I was occupied."
"The footage from last night is still making the rounds in the tactical room." Katherine reached for the cleaning solution. Applied it with the precise unhurried movements of someone who knew exactly how much force was necessary and how much would cause unnecessary pain. "Garrick's team has been running the telemetry trying to figure out the physics of the train crossing."
"I've heard."
"They keep arriving at answers they don't like." A brief pause. "The consensus is that it wasn't physically possible."
"And yet."
Katherine looked up at her. Not a quick glance — a real look, the kind that took its time. The look of someone who has spent years working with enhanced personnel and knows the difference between people who survive things by luck and people who survive things because they are, at some measurable level, built differently. The look of a person who has just run a calculation and is not surprised by the result.
"Enhanced?" she said.
"Moderately."
"Mm." She turned back to the wound. "That explains the healing rate on this, then. It's further along than it should be."
"Is that a medical opinion?"
"It's an observation." Katherine applied the next layer of treatment with the same methodical calm. "I worked with three enhanced operatives before this posting. Two of them had the same problem you do."
"Which problem?"
"Treating injuries as administrative inconveniences."
Aveline said nothing.
"For what it's worth," Katherine said, "the hand is actually in reasonable shape. Better than it should be, given the timing. Whatever you're running on, it's doing something useful." She began the redressing. "You got lucky with the angle. Millimetres to the right and we'd be having a different conversation."
"A shorter one."
"Considerably."
Something settled between them that wasn't quite silence and wasn't quite conversation — the particular register of two people who have taken each other's measure and found it adequate, who understand that this is not the last time they will be in this room together and are both operating on that assumption without having stated it.
"Try not to need me again before noon," Katherine said, when she was done.
"No promises," Aveline said.
"I know," Katherine said. She was already turning back to her station. "I've started keeping your chart in the top drawer."
Conference Room | 9:07 AM
The conference room was three floors up and already busy when Adrian arrived.
Maps on the screens. Satellite imagery. Dense blocks of text that would require reading, analysis, understanding — right now it was visual noise organized in the service of a problem that kept getting bigger every time you looked at it directly.
The quiet particular to rooms where everyone present is trying to think faster than the problem. That specific frequency of concentration that comes when you've got intelligence that's fragmentary and incomplete and you're trying to build something coherent from it anyway.
Elias was already at the head of the table. He looked like he'd been there for some time — possibly since before the lab briefing, possibly since 3 AM, possibly since the moment the first report crossed his desk and he'd decided he needed to physically occupy a space where he could see all the available information simultaneously and think at it until it stopped being intractable.
Adrian sat. Poured himself coffee from the pot on the side table. It was lukewarm. He drank it anyway.
A few other staff were present — analysts, support, someone from logistics running quiet numbers in the corner but the conversation that mattered, the one that would determine what happened next, was going to be between Elias and Adrian. That was clear from the way Elias was looking at him. The particular look of someone who needs to say things that require an audience of exactly one.
"The green serum," Adrian said, because someone had to start.
"Yes."
"We got the wrong vial."
"You got a vial." Elias's voice was careful. Deliberately precise. "What was in the South Monroe facility was real. It was functional as a nerve agent. What it was not—"
"Was the thing that justified twelve hours of that," Adrian said.
Elias didn't flinch. "The mission parameters were based on the intelligence available. The intelligence indicated the amber serum. The facility housed a related compound — degraded, destabilized, missing the NexoStab-7 — and we retrieved it."
"Which tells us what, exactly?"
"That the amber serum was never there." Elias pulled up a map on the screen. Three points in red. "Or it was moved before you arrived. Either way — the real compound is elsewhere. Which means the South Monroe operation, while operationally successful, was strategically incomplete."
Adrian looked at the map.
South Metro. Ironcliff. Veredian.
"Incomplete is a generous word for it," he said.
"It's the accurate word for it." Elias's voice didn't shift. "You retrieved intelligence. You confirmed the compound exists in a form consistent with Nexo's development timeline. You demonstrated that their South Metro facility has some operational capacity, even if the primary target wasn't there. That is not nothing."
"It's not enough."
"No," Elias said. "It's not."
A moment. The logistics analyst in the corner typed something. Someone's radio crackled down the hall and went quiet.
"Walk me through the other sites," Adrian said.
Elias moved to the map. His finger tracked to the first red dot.
"South Metro — this headquarters — shows no evidence of the amber serum on site. We've been through what we have here. That's been confirmed." He moved on. "Veredian City branch. Our contact there reports nothing irregular. No unusual security protocols, no restricted zone expansions, no anomalous activity patterns."
"Nothing," Adrian said.
"One incident. Approximately three weeks ago. Light noise, described as brief. Then nothing since."
"What kind of noise?"
Elias looked at him steadily. "The report says 'mechanical.' Our contact wasn't specific. Could be equipment installation. Could be a dozen other things."
"Or," Adrian said.
"Or," Elias agreed. He moved his finger to the third dot. "Ironcliff City. Three separate accounts of unusual activity in the lower facility levels over the past six weeks. Increased security rotation. Changes to access protocols for the subterranean levels." He glanced at the report. "And noise complaints from the surrounding block."
"What kind?"
"Described as screaming." He said it the same way he said everything — precisely, without emphasis, the way you deliver information that is factual and terrible and that you need the other person to receive without the delivery getting in the way. "Which stopped. Quickly, and without explanation."
The room was quiet.
Adrian looked at Ironcliff City on the map. He thought about what kind of sounds get described as screaming and then stop quickly and without explanation inside a pharmaceutical facility. He thought about what stopped them. He thought about whether it was better or worse if the screaming stopped because the experiments were concluded, because the subjects were relocated, because sedatives were introduced, because the problem of living test subjects became the problem of disposal.
None of the options were good options. The math only had bad answers.
"And the Veredian incident," Adrian said. "Three weeks ago. After six weeks of Ironcliff activity."
Elias nodded. He saw where Adrian was going.
"If Ironcliff is where they're developing it," Adrian said slowly, "Veredian might be where they're housing the counter. The antidote. The insurance policy."
"That's consistent with their operational model," Elias said. "Compartmentalization. If one facility is compromised, the other remains viable."
"Which means we can't take Ironcliff without knowing what's in Veredian. If we go in hard on Ironcliff and they trigger a failsafe—"
"I'm aware," Elias said.
Adrian pushed back from the table slightly. The exhaustion was catching up with him in force now, settling into his shoulders with the specific weight of a body that has been told it needs to keep going and is running out of the cellular currency to do so. He ran a hand across his face. Thought.
"We can't do this tonight," he said. "I'm not saying we shouldn't do it. I'm saying we can't do it tonight. The team ran twelve hours yesterday, half of which were—" He stopped himself. "We need to be functioning when we go into Ironcliff. We're not functioning right now. Not fully."
"The intelligence window—"
"Will still be open tomorrow," Adrian said. "Or we verify that it won't be, remotely, before we commit to a timeline." He met Elias's gaze. The look of two people who were both right about different parts of the same problem and who were both going to have to make peace with the parts they were wrong about. "I'm not asking for a week. I'm asking for enough time to plan this properly. Ironcliff is not South Monroe. If the screaming is what we think it is, Ironcliff is significantly worse than South Monroe. We go in there with three hours of sleep and a plan built on noise complaints and someone doesn't come back."
Elias was quiet.
It was the quiet of someone doing their own math. Recalibrating. Adjusting for variables that were not going to be fixed by moving faster.
"Forty-eight hours," Elias said. "Maximum. We use that window for remote verification, contact activation at both sites, and full planning. If the intelligence picture changes, the timeline adjusts accordingly."
Adrian looked at him.
"And Garrick?"
"Alert him. Standby, not active."
Adrian pulled out his phone. The call connected on the second ring — Garrick was waiting, had probably been waiting since they left the helipad, had probably known on some level that there would be a second call.
"It's me," Adrian said. "We need you. Not tonight. Forty-eight hours — we'll confirm timing tomorrow."
A long pause on the other end. Garrick processing.
"Right," Garrick said, in the tone of a man who had just confirmed what he'd already suspected and was making peace with it. "And is this going to involve a train?"
Adrian looked at the map. At Ironcliff City. At the three red dots and the space between them and the shape of the problem they were building toward.
"Probably not," he said.
"Probably," Garrick repeated.
"We'll confirm details when we have them."
"Of course you will," Garrick said, and hung up.
Adrian set the phone down.
The room was quiet. The analysts were running their numbers. The satellite imagery on the screen showed Ironcliff City from thirty thousand feet — orderly, industrial, unremarkable from the outside. The kind of city that held its secrets in the lower levels where the satellite couldn't see and the noise complaints got filed and then disappeared.
"We're not wrong about Ironcliff," Adrian said.
"No," Elias said. "I don't think we are."
"Whatever's in there—"
"Is worse than what we found in South Monroe," Elias said. The precision of someone stating a fact they've already accepted. "Yes. In all likelihood."
A silence.
The particular kind. The kind that comes after two exhausted people have made the least bad decision available and are sitting with the weight of it.
Adrian refilled his cup. The coffee was cold now. He drank it anyway.
"We needed that antidote development angle," he said. "Veredian as a contingency. If Ironcliff has the serum and Veredian has the counter—"
"Then our sequencing matters," Elias said. "We can't have them burning Veredian before we get there."
"Which means we need simultaneous ops or we need Veredian locked down before Ironcliff knows we're coming." Adrian turned it over. "That's a different kind of operation than yesterday."
"Considerably," Elias agreed.
"We're going to need more people."
"I'm already making calls."
The room settled back into working quiet. Maps. Numbers. The slow careful architecture of something that needed to go right.
Then a knock sounded at the conference room door.
Adrian already knew who it was. He didn't look up.
Elias looked up.
"Come in," he said.